Clinical Specialties & Body Systems

Deep dives by specialty—organs, systems, and diseases managed by expert teams.

  • 16 Subtopics
  • 5 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Clinical Specialties & Body Systems

Cardiology & Metabolic Health Heart disease, hypertension, lipids, diabetes, and metabolic syndrome. Oncology & Hematology Cancer prevention, screening, therapies, survivorship, and blood disorders. Neurology & Neuroscience Stroke, migraine, epilepsy, neurodegeneration, and movement disorders. Orthopedics & Sports Medicine Bones, joints, tendons; injuries, imaging, and surgical/rehab options. Respiratory & Pulmonology Asthma, COPD, sleep apnea, infections, and environmental lung risks. Gastroenterology & Hepatology Gut health, IBD/IBS, reflux, liver disease, and microbiome research. Endocrinology & Hormones Thyroid, adrenal, reproductive hormones, and metabolic disorders of glands. Nephrology & Urology Kidneys, dialysis, stones, infections, prostate, and continence concerns. Dermatology Skin cancer checks, eczema/psoriasis, acne care, and cosmetic dermatology news. Rheumatology & Autoimmune Arthritis, lupus, vasculitis, biologics, and immune‑modulating therapies. OB‑GYN (Women’s Health) Reproductive health, pregnancy, menopause, and gynecologic care advances. Pediatrics & Adolescent Health Well‑child care, vaccinations, development, and school health issues. Geriatrics & Healthy Aging Falls, cognition, polypharmacy, frailty, and independence strategies. Ophthalmology & Vision Glaucoma, cataracts, macular degeneration, and eye‑care technology updates. ENT (Ear, Nose & Throat) Hearing loss, sinus and allergy care, voice, and sleep‑related airway issues. Dentistry & Oral Health Preventive dentistry, periodontal disease, orthodontics, and oral surgery care.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Clinical Specialties & Body Systems


wfmz.com > news > pr_newswire > pr_newswire_health > alf-s-liver-life-challenge-is-official-charity-partner-of-2026-bank-of-america-chicago-marathon > article_e412c42c-1602-5990-a574-be556eb20706.html

ALF's Liver Life Challenge is Official Charity Partner of 2026 Bank of America Chicago Marathon

48+ min ago   (232+ words) Mostly sunny and pleasant; seasonably mild.. Team ALF Chicago Marathon runners unite to fight liver disease CHICAGO, Oct. 9, 2026 /PRNewswire/ -- American Liver Foundation (ALF) is proud to once again be among the more than 200 non-profits participating as a member of the 2026 Bank…...


wfmz.com > news > pr_newswire > pr_newswire_health > step-one-automotive-group-continues-annual-drive-out-breast-cancer-campaign > article_be437b8a-5644-5f4d-9c54-420fb87c63f7.html

Step One Automotive Group Continues Annual Drive Out Breast Cancer Campaign

1+ hour, 42+ min ago   (357+ words) Mostly sunny and pleasant; seasonably mild.. Drive Out Breast Cancer Step One will donate $1 for every signature collected on its pink Jeep, up to $5000, benefitting Ascension Sacred Heart Foundation. FORT WALTON BEACH, Fla., Oct. 9, 2026 /PRNewswire-PRWeb/ -- Step One Automotive Group is continuing…...


oncnursingnews.com > view > using-biomarker-testing-to-personalize-metastatic-triple-negative-breast-cancer-care

Using Biomarker Testing to Personalize Metastatic Triple-Negative Breast Cancer Care

2+ min ago   (304+ words) NP Theresa Stukus and NP Nelli Zafman discuss the essential role of comprehensive biomarker testing in guiding individualized treatment decisions for patients with metastatic triple-negative breast cancer (mTNBC). NP Zafman explains how assessment of biomarkers, including PD-L1 expression, germline BRCA…...


oncnursingnews.com > view > interpreting-frontline-adc-trial-data-in-metastatic-triple-negative-breast-cancer

Interpreting Frontline ADC Trial Data in Metastatic Triple-Negative Breast Cancer

2+ min ago   (318+ words) NP Theresa Stukus and NP Nelli Zafman discuss key considerations when interpreting emerging frontline clinical trial data for antibody-drug conjugates (ADCs) in metastatic triple-negative breast cancer (mTNBC). The faculty emphasize that results from individual trials should be interpreted within the…...


oncnursingnews.com > view > individualizing-frontline-treatment-selection-in-metastatic-triple-negative-breast-cancer

Individualizing Frontline Treatment Selection in Metastatic Triple-Negative Breast Cancer

2+ min ago   (314+ words) NP Theresa Stukus and NP Nelli Zafman introduce the first clinical scenario featuring a young woman with newly diagnosed metastatic triple-negative breast cancer (mTNBC) and discuss the clinical and personal factors that influence frontline treatment selection. Using this case, the…...


oncnursingnews.com > view > supporting-younger-patients-with-metastatic-triple-negative-breast-cancer

Supporting Younger Patients with Metastatic Triple-Negative Breast Cancer

2+ min ago   (338+ words) NP Theresa Stukus and NP Nelli Zafman discuss the unique challenges of caring for younger patients with metastatic triple-negative breast cancer (mTNBC), emphasizing that treatment planning extends beyond disease management to encompass the patient's personal, family, and professional responsibilities. Using…...


oncnursingnews.com > view > recognizing-and-evaluating-diarrhea-in-metastatic-triple-negative-breast-cancer

Recognizing and Evaluating Diarrhea in Metastatic Triple-Negative Breast Cancer

2+ min ago   (324+ words) NP Theresa Stukus and NP Nelli Zafman introduce the second clinical scenario, focusing on the evaluation and management of new-onset diarrhea in a patient with metastatic triple-negative breast cancer (mTNBC) receiving sacituzumab govitecan in combination with an immune checkpoint inhibitor....


oncnursingnews.com > view > patient-education-for-gastrointestinal-toxicity-in-metastatic-triple-negative-breast-cancer

Patient Education for Gastrointestinal Toxicity in Metastatic Triple-Negative Breast Cancer

2+ min ago   (322+ words) NP Theresa Stukus and NP Nelli Zafman discuss the importance of proactive patient education to support early recognition and management of gastrointestinal toxicities in metastatic triple-negative breast cancer (mTNBC). Building on the previous clinical scenario, NP Zafman explains how comprehensive…...


oncnursingnews.com > case-based-peer-perspectives > optimizing-frontline-treatment-for-metastatic-triple-negative-breast-cancer

Optimizing Frontline Treatment for Metastatic Triple- Negative Breast Cancer | Case-Based Peer Perspectives | Oncology Nursing News

2+ min ago   (527+ words) Oncology NPs discuss new frontline options for metastatic triple-negative breast cancer, using cases to guide therapy choice and manage toxicities. Why first-line choices matter in metastatic TNBC: many miss second-line care, and new antibody-drug conjugates boost survival over chemo. NP…...


oncnursingnews.com > view > managing-oral-and-ocular-toxicities-in-metastatic-triple-negative-breast-cancer

Managing Oral and Ocular Toxicities in Metastatic Triple-Negative Breast Cancer

2+ min ago   (326+ words) NP Theresa Stukus and NP Nelli Zafman discuss practical strategies for preventing, monitoring, and managing oral and ocular toxicities in patients with metastatic triple-negative breast cancer (mTNBC) receiving antibody-drug conjugate therapy. The faculty emphasize the importance of initiating preventive oral…...